nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilazapril—ABCB1—Progesterone—uterine cancer	0.127	0.393	CbGbCtD
Cilazapril—ABCB1—Dactinomycin—uterine cancer	0.1	0.312	CbGbCtD
Cilazapril—ABCB1—Etoposide—uterine cancer	0.0566	0.176	CbGbCtD
Cilazapril—ABCB1—Doxorubicin—uterine cancer	0.0386	0.12	CbGbCtD
Cilazapril—ACE—artery—uterine cancer	0.0119	0.108	CbGeAlD
Cilazapril—SLC15A1—epithelium—uterine cancer	0.00631	0.0571	CbGeAlD
Cilazapril—SLC15A1—renal system—uterine cancer	0.00585	0.0529	CbGeAlD
Cilazapril—SLC15A1—endometrium—uterine cancer	0.00565	0.0512	CbGeAlD
Cilazapril—SLC15A1—mammalian vulva—uterine cancer	0.00547	0.0495	CbGeAlD
Cilazapril—ACE—epithelium—uterine cancer	0.00452	0.0409	CbGeAlD
Cilazapril—ACE—smooth muscle tissue—uterine cancer	0.00436	0.0394	CbGeAlD
Cilazapril—ACE—decidua—uterine cancer	0.00427	0.0386	CbGeAlD
Cilazapril—SLC15A1—vagina—uterine cancer	0.00424	0.0383	CbGeAlD
Cilazapril—ACE—renal system—uterine cancer	0.00419	0.0379	CbGeAlD
Cilazapril—ACE—endometrium—uterine cancer	0.00405	0.0367	CbGeAlD
Cilazapril—ACE—mammalian vulva—uterine cancer	0.00392	0.0355	CbGeAlD
Cilazapril—SLC15A2—uterine cervix—uterine cancer	0.00391	0.0354	CbGeAlD
Cilazapril—SLC15A2—renal system—uterine cancer	0.00366	0.0331	CbGeAlD
Cilazapril—SLC15A2—endometrium—uterine cancer	0.00353	0.032	CbGeAlD
Cilazapril—ACE—female reproductive system—uterine cancer	0.00336	0.0304	CbGeAlD
Cilazapril—ACE—female gonad—uterine cancer	0.00306	0.0277	CbGeAlD
Cilazapril—SLC15A2—female reproductive system—uterine cancer	0.00293	0.0265	CbGeAlD
Cilazapril—SLC15A2—female gonad—uterine cancer	0.00266	0.0241	CbGeAlD
Cilazapril—SLC15A2—vagina—uterine cancer	0.00265	0.024	CbGeAlD
Cilazapril—Benazepril—MTHFR—uterine cancer	0.00254	1	CrCbGaD
Cilazapril—ABCB1—myometrium—uterine cancer	0.00203	0.0184	CbGeAlD
Cilazapril—ACE—lymph node—uterine cancer	0.00196	0.0178	CbGeAlD
Cilazapril—SLC15A2—lymph node—uterine cancer	0.00171	0.0155	CbGeAlD
Cilazapril—ABCB1—epithelium—uterine cancer	0.00159	0.0144	CbGeAlD
Cilazapril—ABCB1—uterine cervix—uterine cancer	0.00158	0.0143	CbGeAlD
Cilazapril—ABCB1—decidua—uterine cancer	0.0015	0.0136	CbGeAlD
Cilazapril—ABCB1—renal system—uterine cancer	0.00148	0.0134	CbGeAlD
Cilazapril—ABCB1—endometrium—uterine cancer	0.00143	0.0129	CbGeAlD
Cilazapril—ABCB1—mammalian vulva—uterine cancer	0.00138	0.0125	CbGeAlD
Cilazapril—ABCB1—uterus—uterine cancer	0.00131	0.0119	CbGeAlD
Cilazapril—ABCB1—female reproductive system—uterine cancer	0.00118	0.0107	CbGeAlD
Cilazapril—ABCB1—female gonad—uterine cancer	0.00108	0.00974	CbGeAlD
Cilazapril—ABCB1—vagina—uterine cancer	0.00107	0.00968	CbGeAlD
Cilazapril—Nausea—Progesterone—uterine cancer	0.000742	0.00131	CcSEcCtD
Cilazapril—Renal failure acute—Doxorubicin—uterine cancer	0.000731	0.00129	CcSEcCtD
Cilazapril—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	0.000729	0.00129	CcSEcCtD
Cilazapril—Feeling abnormal—Dactinomycin—uterine cancer	0.000728	0.00129	CcSEcCtD
Cilazapril—Ill-defined disorder—Etoposide—uterine cancer	0.000727	0.00129	CcSEcCtD
Cilazapril—Anaemia—Etoposide—uterine cancer	0.000724	0.00128	CcSEcCtD
Cilazapril—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000722	0.00128	CcSEcCtD
Cilazapril—Hot flush—Doxorubicin—uterine cancer	0.000721	0.00128	CcSEcCtD
Cilazapril—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00072	0.00127	CcSEcCtD
Cilazapril—Migraine—Epirubicin—uterine cancer	0.000718	0.00127	CcSEcCtD
Cilazapril—Menopausal symptoms—Doxorubicin—uterine cancer	0.000715	0.00127	CcSEcCtD
Cilazapril—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000714	0.00126	CcSEcCtD
Cilazapril—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000713	0.00126	CcSEcCtD
Cilazapril—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000709	0.00126	CcSEcCtD
Cilazapril—Renal impairment—Doxorubicin—uterine cancer	0.000709	0.00126	CcSEcCtD
Cilazapril—Malaise—Etoposide—uterine cancer	0.000706	0.00125	CcSEcCtD
Cilazapril—Face oedema—Epirubicin—uterine cancer	0.000704	0.00125	CcSEcCtD
Cilazapril—Vertigo—Etoposide—uterine cancer	0.000704	0.00125	CcSEcCtD
Cilazapril—Leukopenia—Etoposide—uterine cancer	0.000701	0.00124	CcSEcCtD
Cilazapril—Purpura—Doxorubicin—uterine cancer	0.0007	0.00124	CcSEcCtD
Cilazapril—Abdominal pain—Dactinomycin—uterine cancer	0.000698	0.00124	CcSEcCtD
Cilazapril—ABCB1—lymph node—uterine cancer	0.000692	0.00626	CbGeAlD
Cilazapril—Cardiac failure—Doxorubicin—uterine cancer	0.000691	0.00122	CcSEcCtD
Cilazapril—Loss of consciousness—Etoposide—uterine cancer	0.000688	0.00122	CcSEcCtD
Cilazapril—Cerebrovascular accident—Doxorubicin—uterine cancer	0.000688	0.00122	CcSEcCtD
Cilazapril—Ataxia—Epirubicin—uterine cancer	0.000686	0.00121	CcSEcCtD
Cilazapril—Cough—Etoposide—uterine cancer	0.000684	0.00121	CcSEcCtD
Cilazapril—Hypertension—Etoposide—uterine cancer	0.000676	0.0012	CcSEcCtD
Cilazapril—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.000675	0.00119	CcSEcCtD
Cilazapril—Liver function test abnormal—Epirubicin—uterine cancer	0.000673	0.00119	CcSEcCtD
Cilazapril—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000673	0.00119	CcSEcCtD
Cilazapril—Chest pain—Etoposide—uterine cancer	0.000667	0.00118	CcSEcCtD
Cilazapril—Orthostatic hypotension—Epirubicin—uterine cancer	0.000666	0.00118	CcSEcCtD
Cilazapril—Migraine—Doxorubicin—uterine cancer	0.000664	0.00118	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000662	0.00117	CcSEcCtD
Cilazapril—Discomfort—Etoposide—uterine cancer	0.000659	0.00117	CcSEcCtD
Cilazapril—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000657	0.00116	CcSEcCtD
Cilazapril—Face oedema—Doxorubicin—uterine cancer	0.000651	0.00115	CcSEcCtD
Cilazapril—Hypersensitivity—Dactinomycin—uterine cancer	0.000651	0.00115	CcSEcCtD
Cilazapril—Confusional state—Etoposide—uterine cancer	0.000645	0.00114	CcSEcCtD
Cilazapril—Ataxia—Doxorubicin—uterine cancer	0.000634	0.00112	CcSEcCtD
Cilazapril—Asthenia—Dactinomycin—uterine cancer	0.000634	0.00112	CcSEcCtD
Cilazapril—Thrombocytopenia—Etoposide—uterine cancer	0.000626	0.00111	CcSEcCtD
Cilazapril—Tachycardia—Etoposide—uterine cancer	0.000624	0.0011	CcSEcCtD
Cilazapril—Liver function test abnormal—Doxorubicin—uterine cancer	0.000623	0.0011	CcSEcCtD
Cilazapril—Skin disorder—Etoposide—uterine cancer	0.000621	0.0011	CcSEcCtD
Cilazapril—Hyperhidrosis—Etoposide—uterine cancer	0.000618	0.00109	CcSEcCtD
Cilazapril—Pancreatitis—Epirubicin—uterine cancer	0.000618	0.00109	CcSEcCtD
Cilazapril—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000616	0.00109	CcSEcCtD
Cilazapril—Angina pectoris—Epirubicin—uterine cancer	0.000614	0.00109	CcSEcCtD
Cilazapril—Anorexia—Etoposide—uterine cancer	0.000609	0.00108	CcSEcCtD
Cilazapril—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000608	0.00108	CcSEcCtD
Cilazapril—Bronchitis—Epirubicin—uterine cancer	0.000606	0.00107	CcSEcCtD
Cilazapril—Diarrhoea—Dactinomycin—uterine cancer	0.000604	0.00107	CcSEcCtD
Cilazapril—Hypotension—Etoposide—uterine cancer	0.000597	0.00106	CcSEcCtD
Cilazapril—Dysuria—Epirubicin—uterine cancer	0.000589	0.00104	CcSEcCtD
Cilazapril—Neutropenia—Epirubicin—uterine cancer	0.000589	0.00104	CcSEcCtD
Cilazapril—Pollakiuria—Epirubicin—uterine cancer	0.000582	0.00103	CcSEcCtD
Cilazapril—Photosensitivity reaction—Epirubicin—uterine cancer	0.000575	0.00102	CcSEcCtD
Cilazapril—Paraesthesia—Etoposide—uterine cancer	0.000574	0.00102	CcSEcCtD
Cilazapril—Pancreatitis—Doxorubicin—uterine cancer	0.000572	0.00101	CcSEcCtD
Cilazapril—Dyspnoea—Etoposide—uterine cancer	0.00057	0.00101	CcSEcCtD
Cilazapril—Hyperglycaemia—Epirubicin—uterine cancer	0.000568	0.00101	CcSEcCtD
Cilazapril—Somnolence—Etoposide—uterine cancer	0.000568	0.00101	CcSEcCtD
Cilazapril—Angina pectoris—Doxorubicin—uterine cancer	0.000568	0.00101	CcSEcCtD
Cilazapril—Vomiting—Dactinomycin—uterine cancer	0.000562	0.000994	CcSEcCtD
Cilazapril—Bronchitis—Doxorubicin—uterine cancer	0.000561	0.000993	CcSEcCtD
Cilazapril—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000557	0.000986	CcSEcCtD
Cilazapril—Rash—Dactinomycin—uterine cancer	0.000557	0.000986	CcSEcCtD
Cilazapril—Decreased appetite—Etoposide—uterine cancer	0.000556	0.000984	CcSEcCtD
Cilazapril—Renal failure—Epirubicin—uterine cancer	0.000552	0.000978	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Etoposide—uterine cancer	0.000552	0.000977	CcSEcCtD
Cilazapril—Fatigue—Etoposide—uterine cancer	0.000551	0.000976	CcSEcCtD
Cilazapril—Pain—Etoposide—uterine cancer	0.000547	0.000968	CcSEcCtD
Cilazapril—Constipation—Etoposide—uterine cancer	0.000547	0.000968	CcSEcCtD
Cilazapril—Conjunctivitis—Epirubicin—uterine cancer	0.000546	0.000967	CcSEcCtD
Cilazapril—Neutropenia—Doxorubicin—uterine cancer	0.000545	0.000965	CcSEcCtD
Cilazapril—Dysuria—Doxorubicin—uterine cancer	0.000545	0.000965	CcSEcCtD
Cilazapril—Pollakiuria—Doxorubicin—uterine cancer	0.000539	0.000954	CcSEcCtD
Cilazapril—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000532	0.000942	CcSEcCtD
Cilazapril—Hepatobiliary disease—Epirubicin—uterine cancer	0.000531	0.000941	CcSEcCtD
Cilazapril—Epistaxis—Epirubicin—uterine cancer	0.00053	0.000938	CcSEcCtD
Cilazapril—Sinusitis—Epirubicin—uterine cancer	0.000527	0.000933	CcSEcCtD
Cilazapril—Feeling abnormal—Etoposide—uterine cancer	0.000527	0.000933	CcSEcCtD
Cilazapril—Hyperglycaemia—Doxorubicin—uterine cancer	0.000526	0.000931	CcSEcCtD
Cilazapril—Nausea—Dactinomycin—uterine cancer	0.000525	0.000929	CcSEcCtD
Cilazapril—Agranulocytosis—Epirubicin—uterine cancer	0.000524	0.000928	CcSEcCtD
Cilazapril—Gastrointestinal pain—Etoposide—uterine cancer	0.000523	0.000926	CcSEcCtD
Cilazapril—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000515	0.000913	CcSEcCtD
Cilazapril—Bradycardia—Epirubicin—uterine cancer	0.000513	0.000909	CcSEcCtD
Cilazapril—Renal failure—Doxorubicin—uterine cancer	0.000511	0.000905	CcSEcCtD
Cilazapril—Urticaria—Etoposide—uterine cancer	0.000508	0.000899	CcSEcCtD
Cilazapril—Rhinitis—Epirubicin—uterine cancer	0.000506	0.000895	CcSEcCtD
Cilazapril—Abdominal pain—Etoposide—uterine cancer	0.000505	0.000895	CcSEcCtD
Cilazapril—Conjunctivitis—Doxorubicin—uterine cancer	0.000505	0.000895	CcSEcCtD
Cilazapril—Hypoaesthesia—Epirubicin—uterine cancer	0.000502	0.000889	CcSEcCtD
Cilazapril—Pharyngitis—Epirubicin—uterine cancer	0.000501	0.000886	CcSEcCtD
Cilazapril—Urinary tract disorder—Epirubicin—uterine cancer	0.000498	0.000882	CcSEcCtD
Cilazapril—Urethral disorder—Epirubicin—uterine cancer	0.000494	0.000875	CcSEcCtD
Cilazapril—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000492	0.000871	CcSEcCtD
Cilazapril—Epistaxis—Doxorubicin—uterine cancer	0.00049	0.000868	CcSEcCtD
Cilazapril—Sinusitis—Doxorubicin—uterine cancer	0.000488	0.000864	CcSEcCtD
Cilazapril—Visual impairment—Epirubicin—uterine cancer	0.000486	0.000861	CcSEcCtD
Cilazapril—Agranulocytosis—Doxorubicin—uterine cancer	0.000485	0.000859	CcSEcCtD
Cilazapril—Erythema multiforme—Epirubicin—uterine cancer	0.000477	0.000844	CcSEcCtD
Cilazapril—Bradycardia—Doxorubicin—uterine cancer	0.000475	0.000841	CcSEcCtD
Cilazapril—Hypersensitivity—Etoposide—uterine cancer	0.000471	0.000834	CcSEcCtD
Cilazapril—Tinnitus—Epirubicin—uterine cancer	0.00047	0.000833	CcSEcCtD
Cilazapril—Flushing—Epirubicin—uterine cancer	0.000468	0.000829	CcSEcCtD
Cilazapril—Cardiac disorder—Epirubicin—uterine cancer	0.000468	0.000829	CcSEcCtD
Cilazapril—Rhinitis—Doxorubicin—uterine cancer	0.000468	0.000828	CcSEcCtD
Cilazapril—Hypoaesthesia—Doxorubicin—uterine cancer	0.000464	0.000822	CcSEcCtD
Cilazapril—Pharyngitis—Doxorubicin—uterine cancer	0.000463	0.00082	CcSEcCtD
Cilazapril—Urinary tract disorder—Doxorubicin—uterine cancer	0.000461	0.000816	CcSEcCtD
Cilazapril—Asthenia—Etoposide—uterine cancer	0.000459	0.000812	CcSEcCtD
Cilazapril—Angiopathy—Epirubicin—uterine cancer	0.000458	0.00081	CcSEcCtD
Cilazapril—Urethral disorder—Doxorubicin—uterine cancer	0.000457	0.00081	CcSEcCtD
Cilazapril—Immune system disorder—Epirubicin—uterine cancer	0.000456	0.000807	CcSEcCtD
Cilazapril—Chills—Epirubicin—uterine cancer	0.000453	0.000801	CcSEcCtD
Cilazapril—Pruritus—Etoposide—uterine cancer	0.000452	0.000801	CcSEcCtD
Cilazapril—Arrhythmia—Epirubicin—uterine cancer	0.000451	0.000798	CcSEcCtD
Cilazapril—Visual impairment—Doxorubicin—uterine cancer	0.00045	0.000796	CcSEcCtD
Cilazapril—Alopecia—Epirubicin—uterine cancer	0.000446	0.000789	CcSEcCtD
Cilazapril—Erythema multiforme—Doxorubicin—uterine cancer	0.000441	0.000781	CcSEcCtD
Cilazapril—Diarrhoea—Etoposide—uterine cancer	0.000437	0.000774	CcSEcCtD
Cilazapril—Tinnitus—Doxorubicin—uterine cancer	0.000435	0.00077	CcSEcCtD
Cilazapril—Flushing—Doxorubicin—uterine cancer	0.000433	0.000767	CcSEcCtD
Cilazapril—Cardiac disorder—Doxorubicin—uterine cancer	0.000433	0.000767	CcSEcCtD
Cilazapril—Flatulence—Epirubicin—uterine cancer	0.000433	0.000766	CcSEcCtD
Cilazapril—Tension—Epirubicin—uterine cancer	0.000431	0.000763	CcSEcCtD
Cilazapril—Dysgeusia—Epirubicin—uterine cancer	0.00043	0.000761	CcSEcCtD
Cilazapril—Nervousness—Epirubicin—uterine cancer	0.000426	0.000755	CcSEcCtD
Cilazapril—Angiopathy—Doxorubicin—uterine cancer	0.000423	0.00075	CcSEcCtD
Cilazapril—Dizziness—Etoposide—uterine cancer	0.000423	0.000749	CcSEcCtD
Cilazapril—Muscle spasms—Epirubicin—uterine cancer	0.000422	0.000747	CcSEcCtD
Cilazapril—Immune system disorder—Doxorubicin—uterine cancer	0.000422	0.000746	CcSEcCtD
Cilazapril—Chills—Doxorubicin—uterine cancer	0.000419	0.000741	CcSEcCtD
Cilazapril—Arrhythmia—Doxorubicin—uterine cancer	0.000417	0.000738	CcSEcCtD
Cilazapril—Alopecia—Doxorubicin—uterine cancer	0.000412	0.00073	CcSEcCtD
Cilazapril—Ill-defined disorder—Epirubicin—uterine cancer	0.000407	0.000721	CcSEcCtD
Cilazapril—Vomiting—Etoposide—uterine cancer	0.000406	0.00072	CcSEcCtD
Cilazapril—Anaemia—Epirubicin—uterine cancer	0.000406	0.000719	CcSEcCtD
Cilazapril—Rash—Etoposide—uterine cancer	0.000403	0.000714	CcSEcCtD
Cilazapril—Dermatitis—Etoposide—uterine cancer	0.000403	0.000713	CcSEcCtD
Cilazapril—Headache—Etoposide—uterine cancer	0.0004	0.000709	CcSEcCtD
Cilazapril—Flatulence—Doxorubicin—uterine cancer	0.0004	0.000709	CcSEcCtD
Cilazapril—Tension—Doxorubicin—uterine cancer	0.000399	0.000706	CcSEcCtD
Cilazapril—Dysgeusia—Doxorubicin—uterine cancer	0.000398	0.000704	CcSEcCtD
Cilazapril—Malaise—Epirubicin—uterine cancer	0.000396	0.000701	CcSEcCtD
Cilazapril—Nervousness—Doxorubicin—uterine cancer	0.000395	0.000699	CcSEcCtD
Cilazapril—Vertigo—Epirubicin—uterine cancer	0.000394	0.000698	CcSEcCtD
Cilazapril—Syncope—Epirubicin—uterine cancer	0.000394	0.000697	CcSEcCtD
Cilazapril—Leukopenia—Epirubicin—uterine cancer	0.000393	0.000696	CcSEcCtD
Cilazapril—Muscle spasms—Doxorubicin—uterine cancer	0.000391	0.000692	CcSEcCtD
Cilazapril—Palpitations—Epirubicin—uterine cancer	0.000388	0.000687	CcSEcCtD
Cilazapril—Loss of consciousness—Epirubicin—uterine cancer	0.000386	0.000683	CcSEcCtD
Cilazapril—Cough—Epirubicin—uterine cancer	0.000383	0.000678	CcSEcCtD
Cilazapril—Nausea—Etoposide—uterine cancer	0.00038	0.000672	CcSEcCtD
Cilazapril—Hypertension—Epirubicin—uterine cancer	0.000379	0.000671	CcSEcCtD
Cilazapril—Ill-defined disorder—Doxorubicin—uterine cancer	0.000377	0.000667	CcSEcCtD
Cilazapril—Anaemia—Doxorubicin—uterine cancer	0.000376	0.000665	CcSEcCtD
Cilazapril—Arthralgia—Epirubicin—uterine cancer	0.000374	0.000662	CcSEcCtD
Cilazapril—Chest pain—Epirubicin—uterine cancer	0.000374	0.000662	CcSEcCtD
Cilazapril—Myalgia—Epirubicin—uterine cancer	0.000374	0.000662	CcSEcCtD
Cilazapril—Anxiety—Epirubicin—uterine cancer	0.000373	0.00066	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000371	0.000657	CcSEcCtD
Cilazapril—Discomfort—Epirubicin—uterine cancer	0.000369	0.000654	CcSEcCtD
Cilazapril—Malaise—Doxorubicin—uterine cancer	0.000366	0.000649	CcSEcCtD
Cilazapril—Dry mouth—Epirubicin—uterine cancer	0.000366	0.000647	CcSEcCtD
Cilazapril—Vertigo—Doxorubicin—uterine cancer	0.000365	0.000646	CcSEcCtD
Cilazapril—Syncope—Doxorubicin—uterine cancer	0.000364	0.000645	CcSEcCtD
Cilazapril—Leukopenia—Doxorubicin—uterine cancer	0.000364	0.000644	CcSEcCtD
Cilazapril—Confusional state—Epirubicin—uterine cancer	0.000361	0.00064	CcSEcCtD
Cilazapril—Palpitations—Doxorubicin—uterine cancer	0.000359	0.000636	CcSEcCtD
Cilazapril—Oedema—Epirubicin—uterine cancer	0.000358	0.000635	CcSEcCtD
Cilazapril—Loss of consciousness—Doxorubicin—uterine cancer	0.000357	0.000632	CcSEcCtD
Cilazapril—Cough—Doxorubicin—uterine cancer	0.000355	0.000628	CcSEcCtD
Cilazapril—Shock—Epirubicin—uterine cancer	0.000353	0.000624	CcSEcCtD
Cilazapril—Thrombocytopenia—Epirubicin—uterine cancer	0.000351	0.000621	CcSEcCtD
Cilazapril—Hypertension—Doxorubicin—uterine cancer	0.000351	0.000621	CcSEcCtD
Cilazapril—Tachycardia—Epirubicin—uterine cancer	0.00035	0.000619	CcSEcCtD
Cilazapril—Skin disorder—Epirubicin—uterine cancer	0.000348	0.000616	CcSEcCtD
Cilazapril—Hyperhidrosis—Epirubicin—uterine cancer	0.000346	0.000613	CcSEcCtD
Cilazapril—Arthralgia—Doxorubicin—uterine cancer	0.000346	0.000612	CcSEcCtD
Cilazapril—Myalgia—Doxorubicin—uterine cancer	0.000346	0.000612	CcSEcCtD
Cilazapril—Chest pain—Doxorubicin—uterine cancer	0.000346	0.000612	CcSEcCtD
Cilazapril—Anxiety—Doxorubicin—uterine cancer	0.000345	0.00061	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000344	0.000608	CcSEcCtD
Cilazapril—Discomfort—Doxorubicin—uterine cancer	0.000342	0.000605	CcSEcCtD
Cilazapril—Anorexia—Epirubicin—uterine cancer	0.000342	0.000605	CcSEcCtD
Cilazapril—Dry mouth—Doxorubicin—uterine cancer	0.000338	0.000599	CcSEcCtD
Cilazapril—Hypotension—Epirubicin—uterine cancer	0.000335	0.000593	CcSEcCtD
Cilazapril—Confusional state—Doxorubicin—uterine cancer	0.000334	0.000592	CcSEcCtD
Cilazapril—Oedema—Doxorubicin—uterine cancer	0.000332	0.000587	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000326	0.000578	CcSEcCtD
Cilazapril—Shock—Doxorubicin—uterine cancer	0.000326	0.000578	CcSEcCtD
Cilazapril—Thrombocytopenia—Doxorubicin—uterine cancer	0.000325	0.000575	CcSEcCtD
Cilazapril—Insomnia—Epirubicin—uterine cancer	0.000324	0.000574	CcSEcCtD
Cilazapril—Tachycardia—Doxorubicin—uterine cancer	0.000324	0.000573	CcSEcCtD
Cilazapril—Skin disorder—Doxorubicin—uterine cancer	0.000322	0.00057	CcSEcCtD
Cilazapril—Paraesthesia—Epirubicin—uterine cancer	0.000322	0.00057	CcSEcCtD
Cilazapril—Hyperhidrosis—Doxorubicin—uterine cancer	0.000321	0.000568	CcSEcCtD
Cilazapril—Dyspnoea—Epirubicin—uterine cancer	0.000319	0.000566	CcSEcCtD
Cilazapril—Somnolence—Epirubicin—uterine cancer	0.000319	0.000564	CcSEcCtD
Cilazapril—Anorexia—Doxorubicin—uterine cancer	0.000316	0.00056	CcSEcCtD
Cilazapril—Dyspepsia—Epirubicin—uterine cancer	0.000315	0.000559	CcSEcCtD
Cilazapril—Decreased appetite—Epirubicin—uterine cancer	0.000312	0.000552	CcSEcCtD
Cilazapril—Hypotension—Doxorubicin—uterine cancer	0.00031	0.000549	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000309	0.000548	CcSEcCtD
Cilazapril—Fatigue—Epirubicin—uterine cancer	0.000309	0.000547	CcSEcCtD
Cilazapril—Constipation—Epirubicin—uterine cancer	0.000306	0.000543	CcSEcCtD
Cilazapril—Pain—Epirubicin—uterine cancer	0.000306	0.000543	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000302	0.000535	CcSEcCtD
Cilazapril—Insomnia—Doxorubicin—uterine cancer	0.0003	0.000531	CcSEcCtD
Cilazapril—Paraesthesia—Doxorubicin—uterine cancer	0.000298	0.000527	CcSEcCtD
Cilazapril—Dyspnoea—Doxorubicin—uterine cancer	0.000296	0.000523	CcSEcCtD
Cilazapril—Feeling abnormal—Epirubicin—uterine cancer	0.000295	0.000523	CcSEcCtD
Cilazapril—Somnolence—Doxorubicin—uterine cancer	0.000295	0.000522	CcSEcCtD
Cilazapril—Gastrointestinal pain—Epirubicin—uterine cancer	0.000293	0.000519	CcSEcCtD
Cilazapril—Dyspepsia—Doxorubicin—uterine cancer	0.000292	0.000517	CcSEcCtD
Cilazapril—Decreased appetite—Doxorubicin—uterine cancer	0.000288	0.00051	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000286	0.000507	CcSEcCtD
Cilazapril—Fatigue—Doxorubicin—uterine cancer	0.000286	0.000506	CcSEcCtD
Cilazapril—Urticaria—Epirubicin—uterine cancer	0.000285	0.000504	CcSEcCtD
Cilazapril—Pain—Doxorubicin—uterine cancer	0.000284	0.000502	CcSEcCtD
Cilazapril—Constipation—Doxorubicin—uterine cancer	0.000284	0.000502	CcSEcCtD
Cilazapril—Abdominal pain—Epirubicin—uterine cancer	0.000283	0.000502	CcSEcCtD
Cilazapril—Feeling abnormal—Doxorubicin—uterine cancer	0.000273	0.000484	CcSEcCtD
Cilazapril—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000271	0.00048	CcSEcCtD
Cilazapril—Hypersensitivity—Epirubicin—uterine cancer	0.000264	0.000467	CcSEcCtD
Cilazapril—Urticaria—Doxorubicin—uterine cancer	0.000263	0.000466	CcSEcCtD
Cilazapril—Abdominal pain—Doxorubicin—uterine cancer	0.000262	0.000464	CcSEcCtD
Cilazapril—Asthenia—Epirubicin—uterine cancer	0.000257	0.000455	CcSEcCtD
Cilazapril—Pruritus—Epirubicin—uterine cancer	0.000254	0.000449	CcSEcCtD
Cilazapril—Diarrhoea—Epirubicin—uterine cancer	0.000245	0.000434	CcSEcCtD
Cilazapril—Hypersensitivity—Doxorubicin—uterine cancer	0.000244	0.000433	CcSEcCtD
Cilazapril—Asthenia—Doxorubicin—uterine cancer	0.000238	0.000421	CcSEcCtD
Cilazapril—Dizziness—Epirubicin—uterine cancer	0.000237	0.00042	CcSEcCtD
Cilazapril—Pruritus—Doxorubicin—uterine cancer	0.000235	0.000415	CcSEcCtD
Cilazapril—Vomiting—Epirubicin—uterine cancer	0.000228	0.000403	CcSEcCtD
Cilazapril—Diarrhoea—Doxorubicin—uterine cancer	0.000227	0.000402	CcSEcCtD
Cilazapril—Rash—Epirubicin—uterine cancer	0.000226	0.0004	CcSEcCtD
Cilazapril—Dermatitis—Epirubicin—uterine cancer	0.000226	0.0004	CcSEcCtD
Cilazapril—Headache—Epirubicin—uterine cancer	0.000224	0.000397	CcSEcCtD
Cilazapril—Dizziness—Doxorubicin—uterine cancer	0.000219	0.000388	CcSEcCtD
Cilazapril—Nausea—Epirubicin—uterine cancer	0.000213	0.000377	CcSEcCtD
Cilazapril—Vomiting—Doxorubicin—uterine cancer	0.000211	0.000373	CcSEcCtD
Cilazapril—Rash—Doxorubicin—uterine cancer	0.000209	0.00037	CcSEcCtD
Cilazapril—Dermatitis—Doxorubicin—uterine cancer	0.000209	0.00037	CcSEcCtD
Cilazapril—Headache—Doxorubicin—uterine cancer	0.000208	0.000368	CcSEcCtD
Cilazapril—Nausea—Doxorubicin—uterine cancer	0.000197	0.000349	CcSEcCtD
